Index
Module 16 • Shock & Hemodynamics
Shock Syndromes II
9%
Data Tables
Shock Syndromes II
Mahmoud A. Ammar ~2 min read Module 16 of 20
5
/ 54

Shock Syndromes II

6

Which would best categorize R.M.’s PE?

A.High risk.
B.Intermediate-high risk.
C.Intermediate-low risk.
D.Low risk.
7

After initiating therapeutic heparin and monitoring,

R.M.’s blood pressure is now maintained at 90/50

mm Hg, but his oxygenation continues to worsen,

now requiring 80% Fio2. The medical team has

decided that the patient’s potential benefit from

thrombolytic therapy outweighs the potential risks.

Which is the best approach for this patient’s throm-

bolytic administration?

A.Alteplase 100 mg infused over 2 hours.
B.Catheter-directed thrombolysis (CDT).
C.Alteplase 50 mg infused over 2 hours.
D.Alteplase 0.5 mg/hour by a pulmonary artery

catheter.

8

As you prepare to implement the previously chosen

treatment strategy, R.M. experiences cardiac arrest

with PEA. Which is the most appropriate interven-

tion for managing R.M.’s PE in the ICU setting?

A.Give alteplase 50 mg intravenous push once.
B.Proceed to surgical embolectomy.
C.Give alteplase 100 mg over 2 hours.
D.Abort cardiopulmonary resuscitation.
9

K.A. is a 50-year-old man admitted to the neuro-

critical care unit because of a head trauma causing a

subarachnoid hemorrhage. On ICU day 3, his blood

pressure is 70/50 mm Hg, and he is mechanically

ventilated. K.A. was resuscitated with a normal

saline bolus, and norepinephrine was initiated. A

TTE reveals RV dilation and tricuspid regurgitation,

and a CT scan reveals a filling defect within the pul-

monary arteries, dilatation of the right ventricle of

the heart, and enlargement of the pulmonary artery.

K.A.’s condition continues to worsen, and vaso-

pressin is added for refractory shock. Which is the

best approach for treatment of K.A.’s shock?

A.Place an inferior vena cava filter.
B.Administer alteplase 100 mg infused over 2

hours.

C.Administer alteplase 50 mg infused over 2

hours.

D.Consult

for

possible

catheter-directed

thrombolysis.

Ψ΄Ψ±Ψ­ Ψ§Ω„ΩΩŠΨ―ΩŠΩˆ Ψ§Ω„ΨͺΨΉΩ„ΩŠΩ…ΩŠ β€” Ω…Ψ²Ψ§Ω…Ω†Ψ© Ω…ΨΉ Ψ§Ω„Ω€ PDF
Ψ¨Ψ―Ψ‘ Ψ§Ω„ΨͺΨ΄ΨΊΩŠΩ„ Ω…Ω†: Ψ§Ω„Ψ―Ω‚ΩŠΩ‚Ψ© 4 فΨͺΨ­ ΨΉΩ„Ω‰ YouTube